Johnson & Johnson to pay $230 million fine

In the press statement on the website of the Attorney General’s Office, it was stated that although the drugs containing opioid substances produced by J&J are addictive and deadly in humans, the company accepted to pay a penalty of 230 million dollars in the lawsuit filed in 2019 because it did not provide enough information to the users on this issue.

“The opioid epidemic has wreaked havoc on countless people in New York state and the rest of the country, and has left millions addicted to dangerous and deadly opioids,” James said. made his statement.

In the statement, it was stated that J&J will end the sale of opioids in the whole of America, especially in New York, “Although it will never compensate for the losses of thousands of people who lost their lives or are addicted to opioids throughout our state, this fund will be used to prevent future destruction.” evaluation was made.

It was noted that the lawsuits filed by Attorney General James against other industry companies that produce opioids continue.

J&J’s $2.1 billion fine for years of deliberate use of the cancer-causing substance ‘asbestos’ in baby powder on June 1 was upheld by the appeals court.

Along with Pfizer and Moderna, J&J is among the pharmaceutical companies that have approved the coronavirus vaccine in the USA.

Source: Dünya Gazetesi by

*The article has been translated based on the content of Dünya Gazetesi by If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!